manojkumar retweeted
🎙️ In this weeks episode of Oncology Decoded:
Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, speak about the clinical utility of enfortumab vedotin/pembrolizumab in MIBC and other populations.
Listen here 👉 hubs.li/Q04crM-v0
#blcsm #BladderCancer #Oncology | @mkbupathi @BGarmezy
manojkumar retweeted
More SCRI representation at @GUconference #WORLDGU25! @jeffyoriomd part of an all star panel discussing mrd and better disease monitoring in gu cancers. @SarahCannonDocs @TexasOncology
manojkumar retweeted
Proud of @mkbupathi chairing a session on variant histology @GUconference #worldgu25 @SarahCannonDocs @TheUSONetwork
He represents SCRI well!
Exited to share our newest episode on prostate cancer imaging with @BGarmezy @MikeLattanzi @damiansource @SarahCannonDocs
open.spotify.com/episode/043…
manojkumar retweeted
The first episode on @OncologyDecoded is out on Apple Podcasts and Spotify!
podcasts.apple.com/us/podcas…
cancernetwork.com/podcasts/o…
Listen about perioperative urothelial cancer with @mkbupathi @PGrivasMDPhD and David Morris!
@SarahCannonDocs @TheUSONetwork @SCRIOncology
manojkumar retweeted
Manojkumar Bupathi, MD – Rocky Mountain Cancer Centers; Christina Davis, PharmD, BCOP – University of Colorado; and
Brianna Hoffner, MSN, ANP-BC, AOCNP – University of Colorado take part in the Barriers in Practice panel at the Denver #LearnACI.
interesting human computer interaction lecture, an app based approach to modify behavior #OSUBMISeminars
interesting proposal for "bridging the gap" within the different specialties of BMI #OSUBMISeminars
interesting presentation on nested case control studies #OSUBMISeminars







